Notice of NIDDK's Withdrawal from Participation in PAR-13-364 "Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01)"

Notice Number: NOT-DK-16-012

Key Dates
Release Date:   March 9, 2016

Related Announcements
PAR-13-364      

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to inform applicants that, effective May 8, 2016, NIDDK will no longer be participating in PAR-13-364 "Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01)", and will therefore no longer accept applications in response to this FOA after the May 7, 2016 AIDS Due Date.

Inquiries

Please direct all inquiries to:

Dr. Aaron Pawlyk
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-7299
Email: pawlykac@mail.nih.gov